Herpes Simplex Virus

Pau d'Arco shows antiviral activity, particularly against herpes simplex virus and influenza. Pau d'Arco shows antiviral activity against influenza. The global population aged 60 and over is projected to double within 50 years, eventually exceeding 20% of all regional populations, increasing the HZ and PHN burden. Herpes simplex virus is a common viral infection affecting skin and mucous membranes. PHN is a chronic, painful complication of herpes zoster. HSV-1 can reactivate under conditions of stress, immune suppression, head trauma, or major emotional loss. The Alzheimer's-triggering infection is typically subclinical, brewing slowly over years below the threshold of clinical detection. Stress and trauma activate dormant herpes virus, which enters the brain and triggers the amyloid cascade. The herpes reactivation risk from L-arginine applies to both herpes simplex (cold sores) and herpes zoster (shingles). Excessive L-arginine intake may bring latent herpes viruses out of dormancy, causing outbreaks. HSV-1 has a strong association with Alzheimer's and can cross the blood-brain barrier. Roughly 95% of the population carries HSV-1, and the virus remains dormant in nerve tissue in…